ENLIVEN THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.44 USD | -2.07% |
|
+2.14% | +69.00% |
| May. 20 | Enliven Therapeutics Insider Sold Shares Worth $22,877,262, According to a Recent SEC Filing | MT |
| May. 14 | Enliven Therapeutics Q1 Loss Narrows | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 24.70 | 24.70 | 32.42 |
| Spread/Res. | -5.30% | -5.30% | -27.85% |
| Spread/Supp. | +14.60% | +39.39% | +46.37% |
| Support | 20.41 | 16.78 | 15.98 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- ELVN Stock
- Charts Enliven Therapeutics, Inc.
